These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11056368)

  • 1. SPECT imaging with the D(4) receptor antagonist L-750,667 in nonhuman primate brain.
    Staley JK; Tamagnan G; Baldwin RM; Fujita M; Al Tikriti MS; Eshima L; Thornback J; Roe D; Lu L; Seibyl JP; Innis RB
    Nucl Med Biol; 2000 Aug; 27(6):547-56. PubMed ID: 11056368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans.
    Varrone A; Fujita M; Verhoeff NP; Zoghbi SS; Baldwin RM; Rajeevan N; Charney DS; Seibyl JP; Innis RB
    J Nucl Med; 2000 Aug; 41(8):1343-51. PubMed ID: 10945525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
    Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
    Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements.
    McKeith IG; Bartholomew PH; Irvine EM; Cook J; Adams R; Simpson AE
    Br J Psychiatry; 1993 Nov; 163():597-603. PubMed ID: 8298827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.
    Abi-Dargham A; Krystal JH; Anjilvel S; Scanley BE; Zoghbi S; Baldwin RM; Rajeevan N; Ellis S; Petrakis IL; Seibyl JP; Charney DS; Laruelle M; Innis RB
    Am J Psychiatry; 1998 Nov; 155(11):1550-5. PubMed ID: 9812116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain serotonin2 receptors in major depression: a positron emission tomography study.
    Yatham LN; Liddle PF; Shiah IS; Scarrow G; Lam RW; Adam MJ; Zis AP; Ruth TJ
    Arch Gen Psychiatry; 2000 Sep; 57(9):850-8. PubMed ID: 10986548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
    Kaasinen V; Vilkman H; Hietala J; Någren K; Helenius H; Olsson H; Farde L; Rinne J
    Neurobiol Aging; 2000; 21(5):683-8. PubMed ID: 11016537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A; Westera G; Sutter M; Albani C; Kung HF; vonSchulthess GK
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia.
    Meguro K; Yamaguchi S; Yamazaki H; Itoh M; Yamaguchi T; Matsui H; Sasaki H
    Psychiatry Res; 1996 May; 67(1):71-80. PubMed ID: 8797244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
    Fujita M; Tamagnan G; Zoghbi SS; Al-Tikriti MS; Baldwin RM; Seibyl JP; Innis RB
    J Nucl Med; 2000 Sep; 41(9):1552-60. PubMed ID: 10994738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in regional cerebral glucose metabolism during a resting state.
    Gur RC; Mozley LH; Mozley PD; Resnick SM; Karp JS; Alavi A; Arnold SE; Gur RE
    Science; 1995 Jan; 267(5197):528-31. PubMed ID: 7824953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study.
    Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N
    Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates.
    Mach RH; Voytko ML; Ehrenkaufer RL; Nader MA; Tobin JR; Efange SM; Parsons SM; Gage HD; Smith CR; Morton TE
    Synapse; 1997 Apr; 25(4):368-80. PubMed ID: 9097396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experiences with dopamine D2 receptor imaging by means of 2'-iodospiperone and single-photon emission computed tomography.
    Yonekura Y; Saji H; Iwasaki Y; Tsuchida T; Fukuyama H; Shimatsu A; Iida Y; Magata Y; Konishi J; Yokoyama A
    Ann Nucl Med; 1995 Aug; 9(3):131-6. PubMed ID: 8534585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.
    Abi-Dargham A; Zea-Ponce Y; Terriere D; al-Tikriti M; Baldwin RM; Hoffer P; Charney D; Leysen JE; Laruelle M; Mertens J; Innis RB
    Eur J Pharmacol; 1997 Mar; 321(3):285-93. PubMed ID: 9085039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
    Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.